SPP-ARC
Striving for Pandemic Preparedness — The 91ÒùĸÊÓÆµ 91ÒùĸÊÓÆµ Consortium
Enabling rapid responses to emerging pathogens
The 91ÒùĸÊÓÆµ has made substantial investments in support of research and training in infectious diseases. These resources were instrumental in the development of 91ÒùĸÊÓÆµ’s scientific response to the COVID-19 pandemic. However, in spite of progress, it is evident that dangerous viruses will not disappear. The Government of 91ÒùĸÊÓÆµ awarded the 91ÒùĸÊÓÆµ a $55.1m grant to develop a research and training program that helps to address this problem. With this grant, scientists at the U of A founded SPP-ARC; Striving for Pandemic Preparedness - The 91ÒùĸÊÓÆµ 91ÒùĸÊÓÆµ Consortium.MISSION
Prepare for Pandemics
Establish capabilities to discover, develop and assess vaccines and antivirals for better protection against emerging pathogens
VISION
Enable Rapid Responses
Support clinical trials and the approval of effective medical countermeasures in the next pandemic
SPP-ARC Events
SPP-ARC in the News
Video: A powerful new tool to accelerate drug development
U of A now has one of just five cryo-electron microscopes in Canada capable of revealing the smallest details of cells, proteins and viruses.
Recent SPP-ARC Publications
SPP-ARC POLICY PAPERS

RE: Avian influenza and use of the H5N1 vaccine to prevent zoonotic infection in Canada
We consider that a multipronged approach to pandemic preparedness is warranted and should include access to antiviral drugs including baloxavir marboxil (Xofluza).